Edition:
India

Nicox: Zerviate Receives Approval To Carry Out Phase III Clinical Trial In China


Tuesday, 22 Sep 2020 

Sept 22 (Reuters) - Nicox SA ::NICOX’S ZERVIATE RECEIVES IND APPROVAL IN CHINA.PHASE 3 TRIAL IS EXPECTED TO START IN Q4 2020.PARTNER, OCUMENSION THERAPEUTICS, HAS RECEIVED APPROVAL FROM CHINA'S CENTER FOR DRUG EVALUATION OF NATIONAL MEDICAL PRODUCTS ADMINISTRATION TO CARRY OUT PHASE 3 CLINICAL TRIALS ON ZERVIATE (TM).TRIAL FOR TREATMENT OF OCULAR ITCHING ASSOCIATED WITH ALLERGIC CONJUNCTIVITIS.